Literature DB >> 27524870

Cryptic activity within the Type III1 domain of fibronectin regulates tissue inflammation and angiogenesis.

Christina Cho1, Rhiannon Kelsh-Lasher1, Anthony Ambesi1, Paula J McKeown-Longo1.   

Abstract

The fibronectin matrix provides mechanical and biochemical information to regulate homeostatic and pathological processes within tissues. Fibronectin consists of independently-folded modules termed Types I, II and III. In response to cellular contractile force, Type III domains unfold to initiate a series of homophilic binding events which result in the assembly of a complex network of intertwining fibrils. The unfolding of Type III modules provides elasticity to the assembled fibronectin matrix allowing it to function as a dynamic scaffold which provides binding sites for cellular receptors, growth factors and other matrix molecules. Access to bioactive sites within the fibronectin matrix is under complex regulation and controlled through a combination of mechanical and proteolytic activity. Mechanical unfolding of Type III modules and limited proteolysis can alter the topographical display of bioactive sites within the fibronectin fibrils by exposing previously cryptic sites and disrupting functional sites. In this review we will discuss cryptic activity found within the first Type III module of fibronectin and its impact on tissue angiogenesis and inflammation.

Entities:  

Keywords:  Toll-like receptor; Type III domain; VEGF; anastellin; angiogenesis; fibronectin; inflammation; matrix assembly

Year:  2015        PMID: 27524870      PMCID: PMC4981920     

Source DB:  PubMed          Journal:  Curr Top Pept Protein Res        ISSN: 0972-4524


  88 in total

1.  Stimulation of extracellular matrix remodeling by the first type III repeat in fibronectin.

Authors:  R Matthew Klein; Mingzhe Zheng; Anthony Ambesi; Livingston Van De Water; Paula J McKeown-Longo
Journal:  J Cell Sci       Date:  2003-11-15       Impact factor: 5.285

2.  Antiangiogenic proteins require plasma fibronectin or vitronectin for in vivo activity.

Authors:  Ming Yi; Takao Sakai; Reinhard Fassler; Erkki Ruoslahti
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-17       Impact factor: 11.205

3.  Mechanically activated integrin switch controls alpha5beta1 function.

Authors:  Julie C Friedland; Mark H Lee; David Boettiger
Journal:  Science       Date:  2009-01-30       Impact factor: 47.728

4.  Type III and V collagens modulate the expression and assembly of EDA(+) fibronectin in the extracellular matrix of defective Ehlers-Danlos syndrome fibroblasts.

Authors:  Nicoletta Zoppi; Marco Ritelli; Marina Colombi
Journal:  Biochim Biophys Acta       Date:  2012-06-15

Review 5.  Analysing the role of endogenous matrix molecules in the development of osteoarthritis.

Authors:  Nidhi Sofat
Journal:  Int J Exp Pathol       Date:  2009-10       Impact factor: 1.925

6.  Anastellin, the angiostatic fibronectin peptide, is a selective inhibitor of lysophospholipid signaling.

Authors:  Anthony Ambesi; Paula J McKeown-Longo
Journal:  Mol Cancer Res       Date:  2009-02-10       Impact factor: 5.852

7.  Fibronectin fragments in osteoarthritic synovial fluid.

Authors:  D L Xie; R Meyers; G A Homandberg
Journal:  J Rheumatol       Date:  1992-09       Impact factor: 4.666

8.  A major fraction of fibronectin present in the extracellular matrix of tissues is plasma-derived.

Authors:  Federico A Moretti; Anil K Chauhan; Alessandra Iaconcig; Fabiola Porro; Francisco E Baralle; Andrés F Muro
Journal:  J Biol Chem       Date:  2007-07-19       Impact factor: 5.157

9.  Force-induced unfolding of fibronectin in the extracellular matrix of living cells.

Authors:  Michael L Smith; Delphine Gourdon; William C Little; Kristopher E Kubow; R Andresen Eguiluz; Sheila Luna-Morris; Viola Vogel
Journal:  PLoS Biol       Date:  2007-10-02       Impact factor: 8.029

10.  A novel role for the integrin-binding III-10 module in fibronectin matrix assembly.

Authors:  D C Hocking; R K Smith; P J McKeown-Longo
Journal:  J Cell Biol       Date:  1996-04       Impact factor: 10.539

View more
  2 in total

1.  Fibronectin Functions as a Selective Agonist for Distinct Toll-like Receptors in Triple-Negative Breast Cancer.

Authors:  Anthony Ambesi; Pranav Maddali; Paula J McKeown-Longo
Journal:  Cells       Date:  2022-06-30       Impact factor: 7.666

Review 2.  Dissecting Tumor Growth: The Role of Cancer Stem Cells in Drug Resistance and Recurrence.

Authors:  Beatrice Aramini; Valentina Masciale; Giulia Grisendi; Federica Bertolini; Michela Maur; Giorgia Guaitoli; Isca Chrystel; Uliano Morandi; Franco Stella; Massimo Dominici; Khawaja Husnain Haider
Journal:  Cancers (Basel)       Date:  2022-02-15       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.